A group at the University of Texas Southwestern that retracted five papers last year has retracted one more, and has had a paper subjected to an Expression of Concern at the request of the school’s dean.
Shikeagi Kato, an endocrinology researcher who resigned from the University of Tokyo in March 2012 amid an investigation that concluded 43 of his papers should be retracted, has retracted five more papers.
It’s really hard to get papers retracted, police might be best-equipped to handle scientific misconduct investigations, and there’s finally software that will identify likely image manipulation.
Nearly six months after first expressing concern about the validity of a 2010 paper on multiple sclerosis, Nature Medicine has retracted the article for containing “erroneous” data — which in this case don’t seem to have existed, making them more fabricated than wrong.
The paper, “Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease,” came from a group led by Jingwu Zhang, who at the time ran GlaxoSmithKline’s Research and Development Center in Shanghai.
A group of researchers in Ireland has retracted their 2013 article on a possible new method for treating amyotrophic lateral sclerosis — ALS, also commonly called Lou Gehrig’s disease — after identifying errors in several images in the paper.
We tend to stick to retractions in the peer-reviewed literature here at Retraction Watch, although we’ve made exceptions. Today’s post seemed like a good reason to make another exception, because while Nature Publishing Group-owned Scientific American is not a peer-reviewed journal, the science blogosphere and Twitter are lighting up this weekend with strong reactions to the magazine’s removal of a blog post by biologist Danielle Lee.
The incident was first noted by Dr. Rubidium, who wrote yesterday: